Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cue Biopharma Inc buy Oppenheimer Holdings Inc.

Start price
€1.65
09.04.24 / 50%
Target price
€9.19
09.04.25
Performance (%)
-19.39%
Price
€1.33
24.04.24
Summary
This prediction is currently active. The price of Cue Biopharma Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.39%. This prediction currently runs until 09.04.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this prediction
Performance without dividends (%)
Name 1w
Cue Biopharma Inc -24.000%
iShares Core DAX® 2.594%
iShares Nasdaq 100 3.553%
iShares Nikkei 225® 0.687%
iShares S&P 500 2.209%

Comments by Oppenheimer_Holdings for this prediction

In the thread Cue Biopharma Inc diskutieren
Prediction Buy
Perf. (%) -19.39%
Target price 9.189
Change
Ends at 09.04.25

Cue Biopharma, Inc. (NASDAQ: CUE) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock.
Ratings data for CUE provided by MarketBeat

Stopped prediction by Oppenheimer_Holdings for Cue Biopharma Inc

buy
Cue Biopharma Inc

Start price
Target price
Perf. (%)
€3.00
22.03.23
€9.27
22.03.24
-42.17%
23.03.24